Found: 1
Select item for more details and to access through your institution.
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 282, doi. 10.1111/j.1365-2125.2011.03968.x
- By:
- Publication type:
- Article